Table 1 CSF CHI3L1 levels in neurodegenerative diseases.
From: In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Condition (n) | Age range (median) | CHI3L1 concentration (range, ng/ml) | CHI3L1 concentration (median, ng/ml) |
|---|---|---|---|
Healthy young controls (n = 12) | <40 | 67-256 | 109 |
MS (n = 10) | 28-58 (48) | 152-697 | 281 |
Aged healthy controls (n = 7) | 60-70 (65) | 139-257 | 218 |
AD (n = 10) | 59-86 (75) | 153-1230 | 212 |
ALS (n = 10) | 32-74 (62.5) | 75-769 | 388 |
Stroke (n = 10) | 60-89 (72) | 160-1065 | 359 |